The biotech industry experiences constant change with progressive knowledge and research emerging in the field every year. Because of these advancements, people are able to receive clearer diagnoses and find more effective treatment options for their conditions.
A certification in regulatory affairs will allow you to enter the biotech industry with knowledge on a wide range of regulations and standards, such as:
- Regulatory submissions
- Post-approval activities
- Regulatory compliance
- The Canadian Food and Drugs Act
- Global Regulatory Strategies
Students in this program will earn a certification covering 10 different modules to prepare them for a career in regulatory affairs. With extensive courses on pharmaceutical practices and procedures delivered in just six weeks, this program is a great stepping stone to entering the biotech industry as a professional. Read on to learn more about top biotech trends in 2021 that will inspire you to get involved.
Improvements in Research Become Grounds for New Drug Developments
The research industry is becoming more expansive, allowing scientists and experts to discover more about the human body and drug interactions each year. This paves the way for a more personalized approach to medicine, improving understanding of how each person requires individualized care based on their existing symptoms, diagnosis, etc.
As new studies emerge, biotech companies develop new drugs to reflect this updated research and maximize these advancements. And as new drugs emerge, regulatory affairs become essential for implementation. The advent of smart technology will drive this continued growth of applicable research, creating an ever-growing field for biotech professionals.
Advances in technology allow for great progress in research and drug development
Advancements in Gene Therapy and Personalized Medicine Require Professionals with a Regulatory Affairs Certification
Healthcare is becoming more and more personalized due to improvements in research methods. An area where this is particularly evident is genetics, where experts can determine a plan of action for an individual based on their genetic predispositions. One module in our regulatory affairs program is Biologics/Biotechnology Products. This course goes into detail on gene therapy in cells derived from plants, insects, or mammalians using viral and bacterial vectors, and industrial technology for producing vaccines.
Gene therapy is attracting a lot of research and development funds as of late, giving clinical trials the chance to take hold. With a regulatory affairs certification, you can become a part of these front lines with the latest biotech implementations, giving you an influential position in protecting the health, wellness, and safety of others.
A regulatory affairs certification will allow you to work for biotech companies to ensure compliance
Financing for Biotech Companies Benefits Many Roles in the Industry
Financing for biotech companies has been on an upward trend in recent years, driven mainly by two factors. The first is the ability to apply data to biology, which relates back to advances in research and genetic engineering. The second is the continued support of drug developers in the fight against cancer and investments in technologies that are applicable to many variations of the disease.
Continued funding leads to advanced technology and further developments in the biotech world
This continued financing provides a foundation for biotech companies to build upon, paving the way for many different roles within the industry. Pharmaceutical companies will always require a department for regulatory affairs, making the job outlook for this position well-rated for at least the next 10 years. And you can only assume that, with the continued need for biotech companies, we’ll be seeing many more of these roles in the future.
Interested in getting started in pharmaceutical regulatory affairs?
Contact AAPS for more information!